United States· US:70518-3844_3f8b345a-f793-fa43-e063-6394a90adc2e
buprenorphine hydrochloride and naloxone hydrochloride dihydrate
A oripavine derivatives product containing buprenorphine hydrochloride and naloxone hydrochloride dihydrate, registered in United States by REMEDYREPACK INC..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- buprenorphine hydrochloride and naloxone hydrochloride dihydrate
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- N02AE
- ATC class
- Oripavine derivatives
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11705183844030 TABLET in 1 BLISTER PACK (70518-3844-0)
Regulatory notes
Same class
Other records under N02AE
Oripavine derivatives, as other registers publish it.
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine and NaloxoneBryant Ranch Prepack
- United StatesBuprenorphine HCl and Naloxone HClBryant Ranch Prepack
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e08a6c48-d52a-4c8e-b09f-d68c3d7b9aec GET /v1/drugs/e08a6c48-d52a-4c8e-b09f-d68c3d7b9aec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "56W8MW3EN1",
"rxcui": "203841",
"inchikey": "UAIXRPCCYXNJMQ-RZIPZOSSSA-N",
"display_name": "BUPRENORPHINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBLINGUAL",
"spl_meta": {
"2738feae-316e-426f-971c-5f142ac01b60": {
"match": "brand_token",
"title": "BUPRENORPHINE PATCH [RHODES PHARMACEUTICALS LLC]",
"spl_version": "17",
"published_date": "2026-06-01"
}
},
"productid": "70518-3844_3f8b345a-f793-fa43-e063-6394a90adc2e",
"productndc": "70518-3844",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "203326",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 2MG BASE;EQ 0.5MG BASE",
"product_no": "001",
"approval_date": "Jun 27, 2014"
},
{
"rs": true,
"rld": false,
"te_code": "AB",
"strength": "EQ 8MG BASE;EQ 2MG BASE",
"product_no": "002",
"approval_date": "Jun 27, 2014"
}
],
"appl_type": "A"
},
"dea_schedule": "CIII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE",
"proprietary_name": "buprenorphine hydrochloride and naloxone hydrochloride dihydrate",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "ANDA203326",
"marketing_category": "ANDA",
"nonproprietary_name": "buprenorphine hydrochloride and naloxone hydrochloride dihydrate",
"start_marketing_date": "20230829",
"active_numerator_strength": "8; 2"
}See everything about buprenorphine hydrochloride and naloxone hydrochloride dihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.